|
Volumn 14, Issue 2, 2002, Pages 72-79
|
Prophylactic abciximab in elective coronary stenting: results of a randomized trial.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
HEPARIN;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
BLOOD VESSEL TRANSPLANTATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY OBSTRUCTION;
ELECTIVE SURGERY;
EVALUATION;
FEMALE;
FOLLOW UP;
HUMAN;
INCIDENCE;
INSTRUMENTATION;
ITALY;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATION;
PROSPECTIVE STUDY;
RADIOGRAPHY;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
STENT;
AGED;
ANTIBODIES, MONOCLONAL;
ANTICOAGULANTS;
BLOOD VESSEL PROSTHESIS IMPLANTATION;
CORONARY ANGIOGRAPHY;
CORONARY ARTERY BYPASS;
CORONARY RESTENOSIS;
CORONARY STENOSIS;
FEMALE;
FOLLOW-UP STUDIES;
HEPARIN;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
INCIDENCE;
ITALY;
MALE;
MIDDLE AGED;
PLATELET AGGREGATION INHIBITORS;
POSTOPERATIVE COMPLICATIONS;
PROSPECTIVE STUDIES;
STENTS;
SURGICAL PROCEDURES, ELECTIVE;
|
EID: 0036481599
PISSN: 10423931
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (15)
|
References (0)
|